(3α,5α)3-Hydroxypregnan-20-one (3α,5α-THP) Regulation of the HPA Axis in the Context of Different Stressors and Sex.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
18 08 2022
Historique:
received: 08 07 2022
revised: 15 08 2022
accepted: 16 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Corticotropin-releasing factor (CRF) regulates the stress response in the hypothalamus and modulates neurotransmission across the brain through CRF receptors. Acute stress increases hypothalamic CRF and the GABAergic neurosteroid (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP). We previously showed that 3α,5α-THP regulation of CRF is sex and brain region dependent. In this study, we investigated 3α,5α-THP regulation of stress-induced hypothalamic CRF, CRF receptor type 1 (CRFR1), CRF binding protein (CRFBP), pro-opiomelanocortin (POMC), and glucocorticoid receptor (GR) by western blot and circulating corticosterone (CORT) by enzyme-linked immunosorbent assay (ELISA) in male and female Sprague Dawley rats. Tissue was collected after rats were injected with 3α,5α-THP (15 mg/kg, IP) or vehicle 15 min prior to 30 min of restraint stress (RS), or 10 min of forced swim stress (FSS) and 20 min recovery. The initial exposure to a stress stimulus increased circulating CORT levels in both males and females, but 3α,5α-THP attenuated the CORT response only in females after RS. 3α,5α-THP reduced GR levels in male and females, but differently between stressors. 3α,5α-THP decreased the CRF stress response after FSS in males and females, but after RS, only in female rats. 3α,5α-THP reduced the CRFR1, CRFBP, and POMC increases after RS and FSS in males, but in females only after FSS. Our results showed different stress responses following different types of stressors: 3α,5α-THP regulated the HPA axis at different levels, depending on sex.

Identifiants

pubmed: 36009028
pii: biom12081134
doi: 10.3390/biom12081134
pmc: PMC9406198
pii:
doi:

Substances chimiques

Pro-Opiomelanocortin 66796-54-1
Corticotropin-Releasing Hormone 9015-71-8
Pregnanolone BXO86P3XXW
Corticosterone W980KJ009P

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA024095
Pays : United States

Références

Neuron. 2009 Oct 15;64(1):33-9
pubmed: 19840546
Eur J Pharmacol. 2004 Jul 14;495(2-3):103-10
pubmed: 15249158
J Psychiatr Res. 1997 May-Jun;31(3):297-314
pubmed: 9306288
Endocr Rev. 2002 Oct;23(5):687-702
pubmed: 12372848
Front Neuroendocrinol. 2020 Jan;56:100804
pubmed: 31689419
Front Glob Womens Health. 2022 Apr 26;3:823616
pubmed: 35558166
Alcohol Clin Exp Res. 1995 Apr;19(2):350-5
pubmed: 7625568
Sci Rep. 2019 Feb 4;9(1):1220
pubmed: 30718548
Stress. 2011 Jul;14(4):398-406
pubmed: 21663538
Pharmacol Rev. 1991 Dec;43(4):425-73
pubmed: 1775506
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8777-81
pubmed: 8090722
Neuropharmacology. 2021 Mar 15;186:108463
pubmed: 33460689
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1108-12
pubmed: 7755719
J Endocrinol. 2002 Oct;175(1):89-97
pubmed: 12379493
Eur J Pharmacol. 2004 Sep 19;499(1-2):135-46
pubmed: 15363960
Psychopharmacology (Berl). 1987;93(2):226-9
pubmed: 3122256
J Neuroendocrinol. 2021 Jan;33(1):e12916
pubmed: 33270955
Biol Psychiatry. 2017 Dec 15;82(12):866-874
pubmed: 28793974
J Neurosci. 2011 Dec 14;31(50):18198-210
pubmed: 22171026
Front Cell Neurosci. 2014 Apr 09;8:106
pubmed: 24782710
J Biol Chem. 2011 Nov 4;286(44):38703-38713
pubmed: 21940629
Gynecol Endocrinol. 1995 Mar;9(1):1-7
pubmed: 7793294
Eur Neuropsychopharmacol. 2007 Jan;17(1):37-45
pubmed: 16581232
Lancet. 2018 Sep 22;392(10152):1058-1070
pubmed: 30177236
Endocrinology. 1961 May;68:818-24
pubmed: 13756461
Psychopharmacology (Berl). 2014 Sep;231(17):3257-72
pubmed: 24770626
J Clin Endocrinol Metab. 1998 Jun;83(6):2099-103
pubmed: 9626145
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4553-7
pubmed: 1852011
Mol Cell Biol. 2005 Apr;25(8):3076-86
pubmed: 15798195
J Mol Endocrinol. 2004 Jun;32(3):627-48
pubmed: 15171705
Dialogues Clin Neurosci. 2006;8(4):463-77
pubmed: 17290803
Biol Psychiatry. 2008 Nov 1;64(9):820-2
pubmed: 18534557
Nature. 1995 Nov 16;378(6554):287-92
pubmed: 7477349
Psychopharmacology (Berl). 2014 Sep;231(17):3365-74
pubmed: 24435323
Nature. 1991 Jan 31;349(6308):423-6
pubmed: 1846945
Brain Res. 1992 Feb 28;573(2):353-5
pubmed: 1504771
Pharmacol Biochem Behav. 2013 Jan;103(3):568-72
pubmed: 23046854
Mol Endocrinol. 2007 Jan;21(1):138-47
pubmed: 16973756
Eur J Pharmacol. 1996 May 15;303(3):227-34
pubmed: 8813574
Endocrinology. 1997 Sep;138(9):3842-8
pubmed: 9275073
Curr Opin Investig Drugs. 2010 Jan;11(1):63-71
pubmed: 20047160
Exp Gerontol. 1998 Nov-Dec;33(7-8):697-712
pubmed: 9951617
Psychopharmacology (Berl). 2014 Sep;231(17):3437-44
pubmed: 24658404
Biol Reprod. 1979 Apr;20(3):659-70
pubmed: 572241
Clin Dev Immunol. 2013;2013:608654
pubmed: 23690824
Biol Psychiatry. 2001 Jun 15;49(12):1023-39
pubmed: 11430844
Neuropsychopharmacol Rep. 2020 Mar;40(1):73-84
pubmed: 31872573
J Neurosci. 2015 Jan 7;35(1):316-24
pubmed: 25568124
J Biol Chem. 1984 Feb 25;259(4):2166-70
pubmed: 6546571
Endocrinology. 1998 Nov;139(11):4435-41
pubmed: 9794449
Brain Behav Immun. 2014 Nov;42:50-9
pubmed: 24858659
Brain Struct Funct. 2008 Sep;213(1-2):63-72
pubmed: 18696110
Neuroscience. 2015 Aug 6;300:141-54
pubmed: 25981208
Brain Res. 1986 Nov 29;398(2):382-5
pubmed: 2879610
Endocrinology. 2006 Dec;147(12):5549-56
pubmed: 16946006
Psychopharmacology (Berl). 2005 Jul;180(2):215-23
pubmed: 15696320
Regul Pept. 1997 Jul 23;71(1):15-21
pubmed: 9299637
Neuroscience. 1994 Sep;62(1):265-71
pubmed: 7816204
Psychopharmacology (Berl). 2016 May;233(9):1637-50
pubmed: 26847047
Neuropharmacology. 2002 Nov;43(6):1035-43
pubmed: 12423673
Neuropsychopharmacology. 1996 Dec;15(6):533-40
pubmed: 8946427
Nat Genet. 1998 Jun;19(2):162-6
pubmed: 9620773
Transl Psychiatry. 2021 Feb 26;11(1):145
pubmed: 33637705
Science. 1981 Sep 18;213(4514):1394-7
pubmed: 6267699
Trends Pharmacol Sci. 1991 Apr;12(4):141-7
pubmed: 2063480

Auteurs

Giorgia Boero (G)

Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, 3027 Thurston Bowles Building, CB 7178, Chapel Hill, NC 27599, USA.
Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Ryan E Tyler (RE)

Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, 3027 Thurston Bowles Building, CB 7178, Chapel Hill, NC 27599, USA.

Todd K O'Buckley (TK)

Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, 3027 Thurston Bowles Building, CB 7178, Chapel Hill, NC 27599, USA.

Irina Balan (I)

Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, 3027 Thurston Bowles Building, CB 7178, Chapel Hill, NC 27599, USA.

Joyce Besheer (J)

Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, 3027 Thurston Bowles Building, CB 7178, Chapel Hill, NC 27599, USA.
Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

A Leslie Morrow (AL)

Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, 3027 Thurston Bowles Building, CB 7178, Chapel Hill, NC 27599, USA.
Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH